Ascorbic Acid: Clinical Trials

6 trials of Ascorbic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Recruiting 6
Phase 31Recruiting 1

Follow Ascorbic Acid: new trials by email Literature Review of Ascorbic Acid trials Research Report on Ascorbic Acid

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery
Ophthalmic solution (matching formulation without ascorbic acid), Ascorbic acid ophthalmic solution 5% - Corneal Endothelial Cell Loss, Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery
Phase 2RecruitingCaravel Oculus Pty Ltd2002026-07-282026-08-06
Gingival Hyperpigmentation Treatment
Vitamin c and glutathione, Surgical depigmentation - Gingival Pigmentation, Depigmentation
Phase 2RecruitingCairo University302025-08-012026-05-19
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
Metformin, Rapamycin, Naltrexone - Longevity, GLP-1
Phase 2 / Phase 3RecruitingAgelessRx1502024-12-172025-07-30
Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty
Vitamin C, Placebo - Chronic Pain, Knee Pain Chronic
Phase 2RecruitingUniversity Health Network, Toronto4002024-04-162026-06-23
Combining Active and Passive DNA Hypomethylation
Vitamin C, Placebo - Myelodysplastic Syndromes, Acute Myeloid Leukemia
Phase 2RecruitingKirsten Grønbæk1962019-09-112024-04-17
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Ascorbic Acid, Carboplatin, Cisplatin - Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Phase 2RecruitingMayo Clinic802018-03-232026-09-28

Conditions studied

Leukemia, Myelomonocytic, Chronic (2)  ·  Chronic Pain (1)  ·  Corneal Endothelial Cell Loss (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Myelodysplastic Syndromes (1)  ·  Pain, Postoperative (1)  ·  Vitiligo (1)

Sponsors

AgelessRx (1)  ·  Cairo University (1)  ·  Caravel Oculus Pty Ltd (1)  ·  Kirsten Grønbæk (1)  ·  Mayo Clinic (1)  ·  University Health Network, Toronto (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Sweden (1)

Top investigators

Ali Al-Mousawi, MD (1)  ·  Harman Chaudhry, MD (1)  ·  James Khan, MD (1)  ·  Jesse Wolfstadt, MD (1)  ·  Nourhan A Abdullah, Phd (1)  ·  Raman Mundi, MD (1)  ·  Stefanie Morgan, PhD (1)  ·  Stine Ulrik Mikkelsen, MD, PhD (1)  ·  Thomas E Witzig, M.D. (1)

Results publications

PMID 39352751

NIH funding

P50CA097274 (1)